Nóra Kutszegi
Nóra Kutszegi
Verified email at med.semmelweis-univ.hu
Title
Cited by
Cited by
Year
Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance
O Lautner-Csorba, A Gézsi, ÁF Semsei, P Antal, DJ Erdélyi, G Schermann, ...
BMC medical genomics 5 (1), 42, 2012
592012
Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis
O Lautner-Csorba, A Gézsi, DJ Erdélyi, G Hullám, P Antal, ÁF Semsei, ...
PloS one 8 (8), e69843, 2013
432013
Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma
M Hegyi, A Arany, AF Semsei, K Csordas, O Eipel, A Gezsi, N Kutszegi, ...
Oncotarget 8 (6), 9388, 2017
162017
HLA-DRB1* 07: 01–HLA-DQA1* 02: 01–HLA-DQB1* 02: 02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia
N Kutszegi, X Yang, A Gézsi, G Schermann, DJ Erdélyi, ÁF Semsei, ...
haematologica 102 (9), 1578-1586, 2017
142017
Subgroups of paediatric acute lymphoblastic leukaemia might differ significantly in genetic predisposition to asparaginase hypersensitivity
N Kutszegi, ÁF Semsei, A Gézsi, JC Sági, V Nagy, K Csordás, Z Jakab, ...
PloS one 10 (10), e0140136, 2015
142015
In interaction with gender a common CYP3A4 polymorphism may influence the survival rate of chemotherapy for childhood acute lymphoblastic leukemia
A Gézsi, O Lautner-Csorba, DJ Erdélyi, G Hullám, P Antal, ÁF Semsei, ...
The pharmacogenomics journal 15 (3), 241-247, 2015
132015
Pharmacogenetics of anthracyclines
JC Sági, N Kutszegi, A Kelemen, LE Fodor, A Gézsi, GT Kovács, ...
Pharmacogenomics 17 (9), 1075-1087, 2016
92016
Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma
JC Sági, B Egyed, A Kelemen, N Kutszegi, M Hegyi, A Gézsi, ...
BMC cancer 18 (1), 704, 2018
52018
Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia
A Rzepiel, N Kutszegi, A Gézsi, JC Sági, B Egyed, G Péter, H Butz, ...
Journal of translational medicine 17 (1), 372, 2019
32019
New and traditional directions in the biology and management of childhood acute lymphoblastic leukemia
B Egyed, G Kovács, N Kutszegi, A Rzepiel, JS Csányiné, DJ Erdélyi, ...
Orvosi hetilap 159 (20), 786-797, 2018
3*2018
Extracellular vesicles and their role in hematological malignancies
A Rzepiel, N Kutszegi, JS Cs, A Kelemen, K Pálóczi, E Buzás, DJ Erdélyi
Orvosi hetilap 157 (35), 1379-1384, 2016
1*2016
GENETIC RISK FACTORS OF ANTHRACYCLINE CARDIOTOXICITY–RELEVANT POLYMORPHISMS IDENTIFIED IN ENZYMES AND TRANSPORTERS OF ANTHRACYCLINE PHARMACOKINETICS: PQ001
N Kutszegi, A Semsei, O Lautner-Csorba, M Hegyi, J Szabolcs, G Benyo, ...
Pediatric Blood & Cancer 59 (6), 2012
12012
980 genetic risk factors of neurotoxicity during chemotherapy
A Semsei, O Lautner-Csorba, G Schermann, N Kutszegi, A Falus, ...
european journal of cancer 48, S236, 2012
12012
MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia
B Egyed, N Kutszegi, JC Sági, A Gézsi, A Rzepiel, T Visnovitz, P Lőrincz, ...
Journal of translational medicine 18 (1), 1-12, 2020
2020
New Liquid Biopsy Markers for the Detection of Central Nervous System Involvement in Childhood Acute Leukemia
B Egyed, JC Sági, N Kutszegi, A Gézsi, A Rzepiel, C Szalai, GT Kovács, ...
Clinical Lymphoma, Myeloma and Leukemia 19, S187-S188, 2019
2019
Circulating microRNAs as Potential Minimal Residual Disease Biomarkers in Pediatric Acute Lymphoblastic Leukemia
A Rzepiel, N Kutszegi, B Egyed, A Gézsi, JS Csányi, ÁF Semsei, C Szalai, ...
Clinical Lymphoma, Myeloma and Leukemia 19, S193, 2019
2019
Pharmacogenetic Study of the Central Nervous System in Pediatric Acute Lymphoblastic Leukemia
JC Sagi, A Artner, A Kelemen, B Egyed, A Rzepiel, N Kutszegi, A Gezsi, ...
Clinical Lymphoma, Myeloma and Leukemia 19, S189-S190, 2019
2019
Monitoring the potential role of circulating miR-181b-5p in minimal residual disease in paediatric acute lymphoblastic leukaemia
N Kutszegi, A Rzepiel, A Gézsi, M Papp, B Egyed, H Butz, JC Csányi, ...
Journal of Extracellular Vesicles 7, 241-241, 2018
2018
Circulating microRNAs as potential biomarkers of pediatric acute lymphoblastic leukemia
A Rzepiel, N Kutszegi, B Egyed, A Gézsi, JC Csányi, ÁF Semsei, G Nyírő, ...
Journal of Extracellular Vesicles 7, 148-148, 2018
2018
Génpolimorfizmusok szerepének vizsgálata gyógyszermellékhatások kialakulásában akut limfoblasztos leukémiában
N Kutszegi
2018
The system can't perform the operation now. Try again later.
Articles 1–20